reviewTop 1% cited
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
European Urology · 2015 · Vol. 69(2) · pp. 300–310
Jakub Dobruch✉Siamak Daneshmand(University of Southern California)Margit Fisch(University Medical Center Hamburg-Eppendorf)Yair Lotan(The University of Texas Southwestern Medical Center)Aidan P. Noon(Mount Sinai Hospital)Matthew J. Resnick(Vanderbilt University Medical Center)Shahrokh F. Shariat(Medical University of Vienna)Alexandre R. Zlotta(University of Toronto)Stephen A. Boorjian(Mayo Clinic in Arizona)
Bladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesColorectal Cancer Screening and DetectionMedicineBladder cancerCancerIncidence (geometry)OncologyInternal medicineDiseaseGynecology
MeSH terms
Urinary Bladder NeoplasmsCarcinogensFemaleHumansMaleNeoplasm StagingRisk FactorsSex FactorsGonadal Steroid HormonesSurvival Rate
Citations
672
FWCI
21.83
field-weighted impact
References
102
Percentile
100%
vs. same field & year
Citations per year
Cited by
Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018
European Urology · 2018 · 825 citations
References
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
International Journal of Cancer · 2010 · 21,378 citations
Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
Cancer Cell · 2014 · 1,717 citations
Cancer Statistics, 2008
CA A Cancer Journal for Clinicians · 2008 · 10,197 citations
Epidemiology and Risk Factors of Urothelial Bladder Cancer
European Urology · 2012 · 2,155 citations
Cancer statistics, 2015
CA A Cancer Journal for Clinicians · 2015 · 11,899 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.